As reported to coloplast, though not verified a summons was received indicating the following: on or about (b)(6) 2022, patient underwent a surgical procedure to treat her vaginal vault prolapse and stress urinary incontinence during which she was implanted with coloplast restorelle y and altis.Patient suffered complications associated with the pelvic mesh products, including but not limited to, bleeding, recurrent infections, pelvic floor disfunction, pelvic pain, vaginal pain, abdominal pain, abnormal vaginal discharge, dyspareunia, urinary urgency problems, scarring, and difficulty with daily activities, which ultimately required surgical intervention and removal of mesh on (b)(6) 2023.
|